Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “SALIVATION”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 505 records · Page 28Linked to original sources
PubMed1976

The influence of various factors on fluid secretion by in vitro salivary glands of ixodid Ticks.

1. Salivary glands of the female ixodid tick, Dermacentor andersoni, secrete fluid in vitro when bathed in a slightly modified version of the mammalian tissue culture medium 'TC 199'. 2. Rate of salivation in vitro increases with progression of feeding, but there is no comparable increase in dry weight of the salivary glands during the early phase of engorgement. Engorged ticks secreted at only 25% the rate of 90-250 mg ticks, indicating that salivary gland degeneration has already begun in the very early post-engorgement stage. 3. A salivary gland stimulating factor can be detected in the nervous system but not in other tissues. 4. Male salivary glands secrete at only 1/20th the rate of female glands. Thus males probably do not use their salivary glands as osmoregulatory organs. 5. From the uniform lack of response to ACh and uniform response to DA in 7 ixodid tick species, it is suggested that the control of salivation is similar throughout the ixodid family.

Acetylcholine↗
PubMed1987

[Evaluation of tiquizium bromide (HSR-902) as an antiulcer agent].

The effects of HSR-902, an antimuscarinic agent, on development of various gastric and duodenal lesions, gastric secretion, pupil size and salivation in rats were compared with those of pirenzepine.2HC1 (pirenzepine, antiulcer agent) and timepidium bromide (timepidium, antispasmodic). 1) HSR-902 (10-100 mg/kg), given orally, dose-dependently inhibited the developments of gastric lesions induced by water-immersion stress, aspirin, indomethacin, serotonin and reserpine and duodenal lesions induced by cysteamine and mepirizole. The activities of HSR-902 were almost equal or somewhat more potent than those of pirenzepine, and they were more potent than those of timepidium. 2) HSR-902 (30 and 100 mg/kg, p.o.), when examined using pylorus-ligated preparations, dose-dependently inhibited the gastric acid output, pepsin output, and gastric acid and pepsin concentrations, but did not inhibit the gastric volume (HSR-902, in a higher dose, slightly increased the gastric volume.). Pirenzepine (100 mg/kg, p.o.), like atropine sulfate, inhibited the gastric volume, acid output and pepsin output, but did not inhibit the gastric acid and pepsin concentrations. Timepidium (100 mg/kg, p.o.), however, hardly influenced these parameters except for increasing the gastric volume. 3) HSR-902 (100 mg/kg, p.o.) induced the mydoriasis and inhibited the pilocarpine-induced salivation, and its activities were less potent than those of pirenzepine. These results suggest that HSR-902 is a promising agent for the treatment of peptic ulcer.

Animals↗
PubMed1990

Pharmacological and biochemical assessment of SM-10888, a novel cholinesterase inhibitor.

The effects of the compound SM-10888 (9-amino-8-fluoro-1,2,3,4-tetrahydro-2,4-methanoacridine citrate) in a number of pharmacological and biochemical tests were studied and compared to those of tacrine (THA), amiridin, HP-029 and physostigmine. SM-10888 inhibited cholinesterase activity (IC50: 2.3 x 10(-7) M) in rat cortical P2 fraction with almost the same potency as THA, while SM-10888 was 2-4 times more potent than amiridin and HP-029, but about 10 times less potent than physostigmine. When given to mice p.o., SM-10888 induced central (hypothermia) and peripheral (salivation) cholinergic effects. When the ratio of the ED50 value for hypothermia to that for salivation was regarded as the index of the selectivity to the central nervous system (CNS), SM-10888 was shown to be about 3 times more selective to the CNS than the other four drugs in mice. The minimum effective dose of SM-10888 for its increasing effect on acetylcholine (ACh) content in the mouse cerebral cortex was about 10 times higher than that of physostigmine, but 5-10 times lower than those of THA, amiridin and HP-029. These results suggest that SM-10888 is an adequate drug for increasing the brain ACh content with less peripheral cholinergic side effects than THA, amiridin, HP-029 and physostigmine.

Aminacrine↗
PubMed1990

[Acute toxicity study of buspirone hydrochloride in mice, rats and dogs].

Buspirone hydrochloride (abbr. to BH), an anxiolytic drug, was examined for its intravenous, subcutaneous or oral acute toxicity using Crj: CD-1 (ICR) mice, Crj: CD (Sprague-Dawley) rats and beagle dogs of both sexes. The results obtained were summarized as follows: 1. Drug-related toxic signs included decreased activity and convulsions accompanied with salivation and opisthotonus in mice and rats treated with BH regardless of administration routes, and tremors and clonic convulsions accompanied with salivation in dogs treated with BH orally. 2. Pathological examinations revealed distention of the stomach in dead rats treated with BH orally, and hypersecretion of gastric juice and alterations (viz. edema, necrosis and petechia) on the superficial mucous membrane in the gastropyloric region in dead dogs treated with BH orally. 3. The cause of death was considered to be due to respiratory insufficiency in every species of animals examined. 4. LD50 values (mg/kg) were as follows: [table: see text] 5. No sex differences were observed in every species of animals regardless of administration routes on the basis of toxicological parameters examined.

Administration, Oral↗
PubMed1995

[Single dose toxicity studies of montirelin hydrate(NS-3) in mice, rats and dogs].

The single dose toxicity studies of montirelin hydrate (NS-3), a new drug for the treatment of disturbance of consciousness, were conducted in Slc:ddY mice, Slc:SD rats, and beagle dogs of both sexes. The drug was administered intravenously (i.v.) to mice, rats and dogs, and intramuscularly (i.m.) to mice and rats. The animals were observed for 14 days after administration. LD50 values were more than 500 mg/kg and 200 mg/kg in mice and rats, respectively, by the i.v. route, and more than 20 mg/kg in both animal species by the i.m. route. In dogs, the minimum lethal dose was more than 200 mg/kg by the i.v. route. Mice that received more than 125 mg/kg by the i.v. route showed tremor and a decrease in locomotor activity during administration and for 30 min thereafter. Mice that received more than 5 mg/kg by the i.m. route showed tremor 5 min after administration and for 2 hr thereafter. Rats that received more than 50 mg/kg by the i.v. route showed tremor, and those that received 200 mg/kg by the same route showed a decrease in locomotor activity and ataxic gait, during and immediately after administration. Rats that received more than 5 mg/kg by the i.m. route showed tremor, and those that received 20 mg/kg by the same route showed salivation 5 min after administration and for 30 min thereafter. Dogs that received more than 12.5 mg/kg by the i.v. route revealed excitement, biting, vocalization, mydriasis, salivation, urination, defecation, licking chops, vomiting, increase in heart rate, panting, hyperthermia, tremor and conjunctival injection during administration and for 6 hr thereafter. The body weight, food consumption and water consumption, and pathological findings showed no changes attributable to the dosing of montirelin hydrate in any animal.

Animals↗
PubMedDate not supplied

Interaction of chlorpromazine and nortriptyline in patients with schizophrenia.

Seven male inpatients suffering from acute schizophrenia were treated with chlorpromazine elixir 100mg 8-hourly for 9 weeks. Nortriptyline 50mg 8-hourly was added during weeks 4, 5 and 6. Plasma chlorpromazine concentrations, antipyrine plasma half-life, blood pressure, pulse rate, pupil size, salivation, handwriting and clinical state were measured at weekly intervals. Plasma chlorpromazine concentrations rose when nortriptyline was added, and the antipyrine plasma half-life was prolonged. Blood pressure dropped on institution of chlorpromazine and dropped further with the addition of nortriptyline. The pulse rate rose in a parallel fashion. Pupil size, salivation and handwriting were diminished by chlorpromazine, but hardly affected further by nortriptyline. The addition of nortriptyline dramatically reversed the therapeutic actions of chlorpromazine, mainly through pharmacodynamic interaction. It is concluded that this combination is potentially deleterious, and must be used with care.

Adult↗
PubMed1995

The effect of slaframine on salivary output and subacute and acute acidosis in growing beef steers.

Experiments were conducted to determine 1) the effect of injecting slaframine (SF) on salivary output in growing beef steers and 2) whether increased salivary output after SF injection would inhibit the decrease in ruminal pH that occurs after experimentally induced subacute and acute ruminal acidosis. In Exp. 1 and 2, we measured ruminal pH and salivary output in ruminally and esophageally cannulated beef steers fed an 88% concentrate diet. Injections of 66 or 100 micrograms of SF/kg BW increased salivary flow approximately 50% compared with controls. Those doses were tested in subacute and acute acidosis models using ruminally cannulated beef steers in Exp. 3 and 4, respectively. In these experiments, salivation was assessed indirectly using a visual scoring system. In the subacute acidosis model, SF reduced (P < .10) the decrease in ruminal pH (1.1, .7, and .6 pH units for control, 66, and 100 micrograms of SF/kg BW doses, respectively), and excessive salivation was observed in all SF-injected steers. In the acute acidosis model, there were no differences (P > .10) in ruminal pH at 12 h after injection between control and SF-treated steers. Mean ruminal lactate concentrations for all treatment groups were between 87 and 112 mM. Although treatment with 66 micrograms of SF/kg BW reduced (P < .10) ruminal lactate concentrations, all ruminal lactate concentrations were indicative of acute acidosis. These results indicate that SF will reduce the decrease in ruminal pH associated with subacute acidosis in growing beef steers, but SF does not attenuate acute ruminal acidosis.

Acidosis↗
PubMed1986

Effects of slaframine on ruminant digestive function: resting salivary flow and composition in cattle.

Four esophageal- and ruminal-cannulated Angus steers (avg weight, 308 kg) were used to investigate how salivation is affected by the administration of purified slaframine (SF; 1-acetoxy-6-aminooctahydroindolizine), a cholinergic secretagogue isolated from Rhizoctonia leguminicola. Steers were fed a concentrate diet at twice the net energy requirement for maintenance in hourly increments. In trial 1, a single injection of SF was administered to four steers intramuscularly at 0, 6, 12 and 24-micrograms/kg body weight (BW) in a 4 X 4 Latin-square design. Saliva was collected via esophageal cannula at 15-min intervals 30 min after each feeding, weighted, sampled and reinfused via ruminal cannula over a 10-h period. At 12- and 24-micrograms SF/kg BW, salivary flow was 31 to 43% greater (P less than .01) than at 0- or 6-micrograms SF/kg. Response peaked within the first 3 h and returned to baseline levels at 8 h. Buffering capacity and pH of saliva were not different (P greater than .10); however, osmolality and Na concentration increased and K concentration decreased (P less than .10) as salivation rates increased. Feed intake of steers did not appear affected at any level of SF administration. In trial 2, 0-, 12- and 24-micrograms SF/kg BW were repeatedly administered intramuscularly to three steers in a 3 X 3 Latin-square design at 8-h intervals for 24 h. Salivary flow was measured and sampled over the entire 24-h period, as in trial 1. Flow rates were increased 50 to 70% (P less than .01) by SF treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Alkaloids↗
PubMedDate not supplied

Sodium concentration in saliva along the time course of experimental Coriolis sickness.

Procedures designed to evaluate the severity of motion sickness have included subjective reporting of changes in salivation. In order to increase objectivity, we studied the sodium concentration of saliva, which is directly related to the flow rate. Healthy adults with normal vestibular function underwent a modified Coriolis Sickness Susceptibility Index (CSSI) test, utilizing a staircase profile. Saliva was collected without interrupting the stimulus by means of cotton placed beneath the subject's tongue for one minute. Samples were obtained 5 min prior to stimulation, 30 and 45 min following stimulus onset, and/or upon reaching the "nausea II" endpoint. Saliva for analysis by atomic absorption spectrophotometry was obtained by centrifugation of the cotton. A significant difference in sodium concentration was found between the baseline and 30-min sample (p less than 0.01). Although the amount of salivation was rather variable, the pattern of changes in sodium concentration was similar in all experimental cases.

Adult↗
PubMed1981

The effect of pirenzepine and L-hyoscyamine on gastric emptying and salivary secretion in healthy volunteers.

Pirenzepine is used in the treatment of peptic ulcer disease as an inhibitor of gastric acid secretion. Recent studies suggest that the mode of action on the stomach may be selectively anticholinergic. The present study was undertaken to compare the effect of pirenzepine on gastric emptying with the effect of a widely used classical anticholinergic drug and of placebo. In a double-blind double-dummy study nine healthy volunteers received 50 mg pirenzepine twice a day, 0.6 mg L-hyoscyamine twice a day, or two placebo tablets twice a day for 4 days before the gastric emptying test. Gastric emptying of a liquid test meal was measured by the method of George. Maximum salivation capacity was registered by the method of Blum 2 and 4 h after the last dose had been given. Gastric emptying was delayed during L-hyoscyamine, whereas the emptying was slightly accelerated by pirenzepine when compared with placebo. The difference between L-hyoscyamine and pirenzepine was statistically significant for the time in which the volume fell to 75% and 50% (p less than 0.01). The salivation was significantly more inhibited by L-hyoscyamine than by pirenzepine. Pirenzepine in doses inhibiting gastric acid secretion does not delay gastric emptying when compared with an equipotent dose of a classical anticholinergic drug, nor does it inhibit salivary secretion as much as L-hyoscyamine. This study therefore confirms our previous conclusion that pirenzepine may indeed be a 'selective' anticholinergic drug acting on gastric secretion.

Adult↗
PubMed2002

Chewing activity, saliva production, and ruminal pH of primiparous and multiparous lactating dairy cows.

Four multiparous (MP) and four primiparous (PP) ruminally cannulated lactating Holstein cows were used in a double 4 x 4 Latin square design to study the chewing behavior, saliva production, and ruminal pH of cows in the first or subsequent lactation. Cows were fed one of four diets; three total mixed rations containing 40, 50, or 60% silage (DM basis), and a separate ingredient diet containing 50% concentrate. Dry matter intake was higher for MP cows than for PP cows (19.2 vs. 17.1 kg/d) but not as a percentage of body weight (2.97 +/- 0.06%). Multiparous cows spent more time eating than PP cows (260 vs. 213 min/d, respectively), even after adjustment for dry matter intake (13.8 vs. 12.4 min/kg DM). Multiparous cows also spent more time ruminating per day than PP cows (560 vs. 508 min/d, respectively). Eating salivation rate was not affected by parity, but resting salivation rate was higher for MP cows than for PP. Although MP cows spent more time chewing than PP cows, total daily saliva production was only numerically higher for MP cows because the increase in saliva produced during chewing was accompanied by a decrease in saliva produced during resting. Furthermore, pH profiles tended to be lower for MP cows than for PP cows. Multiparous cows may have a greater risk of incurring acidosis than PP cows because increased salivary secretion associated with increased chewing may not sufficiently compensate the increment of fermentation acids produced in the rumen due to high feed intake.

Animals↗
PubMed1998

[Kinetic assessment of salivary secretory response to citric acid. Differences with pilocarpine].

BACKGROUND: Induction of salivation is becoming increasingly popular in the assessment of salivary gland status. Various mechanical or pharmacological procedures are empirically used to produce salivation. Oral stimulation by citric acid (AC) is by far the most used sialagogue procedure. AIM: To characterize the salivary secretory response to AC solutions applied to the dorsolateral tongue surfaces. SUBJECTS AND METHODS: Young healthy women from the upper levels of a medical career (n = 19) participated as volunteers. Salivary volume and UV-absorbing organic material in saliva from single subjects were measured after various protocols of topical stimulation by AC. RESULTS: After a single stimulation by 1-8% AC the salivary flow rate peaked before 30 seconds and recovered the basal level earlier than 2 minutes. Repetitive stimulations at 30-sec intervals kept the flow rate at a maximum. After suspending these stimulations, basal flow rate was recovered before 2 minutes. Repetitive AC-stimulations at 8-min intervals produced a series of identical and independent secretory responses. The concentration of organic material in saliva remained unaltered after the various modes of stimulation. Thus, the profile of organic material secretion was always a direct expression of changes in salivary flow rate. In contrast to AC, the oral administration of the cholinergic agonist pilocarpine (PIL) produced a two-wave salivary response that as a whole lasted for about 30 minutes. In this case the volume and the amount of organic material were at least 10-fold the ones secreted in response to AC. CONCLUSIONS: AC provoked a rapid and short-lived salivary response that differs markedly from the one produced by other secretagogues, like pilocarpine.

Adult↗
PubMed1975

Salivary reactions in dogs with dorsomedial amygdalar lesions.

In dogs with chronic parotid fistula, conditioned salivary reactions reinforced by food were established. After bilateral lesions of the dorsomedial part of the amygdaloid complex, the conditioned salivary reactions were greatly diminished. Also the unconditioned salivation decreased. This decrease was greater in dogs which revealed the whole syndrome of amygdalar aphagia, but it was also evident in hypophagic dogs. In some dogs, the disinhibition of the salivation to negatives CS was also observed. Results show that the dorsomedial amygdala, similarly to lateral hypothalamus, is involved in the regulation of salivary reactions.

Amygdala↗
PubMed2001

Botulinum toxin for treatment of parkinsonian sialorrhea.

AIM: Sialorrhea is one of the main problems of patients with Parkinson's disease (PD). Most of the medications used for the treatment of it are ineffective. We decided to try in such patients local injections of botulinum toxin, type A, into both parotid glands. MATERIAL: 11 patients with clinical diagnosis of idiopathic PD and drooling assessed as at least 2 point on the UPDRS part II and 14 control subjects. METHODS: Salivation was measured by weighting dental rolls before and 2 minutes after insertion at 6 places of highest secretion of saliva in mouth (buccal vestibule, and sublingual area). PD patients were assessed before and one week after injections of 5 units of BOTOX into each parotid salivary gland and the results were compared to the salivation of controls. RESULTS: Average excretion of saliva in PD patients was significantly higher than in controls -0.39 +/- 0.4 g/2 min. (range: 0.02-1.82) vs. 0.19 +/- 0.16 g/2 min. (range: 0.02-0.98) (p = 0.03). After the treatment the average excretion of saliva in PD patients decreased to 0.25 +/- 0.26 g/2 min. (range: 0.004-0.99) and did not differ significantly from controls. All patients improved also according to UPDRS. No side-effects were observed in any of the patients injected. CONCLUSION: Botulinum toxin may be an effective and safe treatment of parkinsonian sialorrhea.

Aged↗
PubMedDate not supplied

[Enzyme diagnosis of human parotid glands and its problems].

The gland-specific enzymes amylase, lysozyme and kallikrein the activities and their dependence on the speed of salivation were studied in normal persons. In these investigations the specification or standard ranges for differentiated secretion states is useful. In contrast to amylase activity, the activities of lysozyme and kallikrein weaken appreciably with increasing speed of salivation. The activity secreted, as measured in time units, increases. In the case of a diseased parotis, a comparison of enzyme activities with the standard values will show a significant reduction of lysozyme and amylase activity in the chronic processes. Acute inflammation affects the amylase activity slightly, but raises the lysozyme activity significantly. Parotid mixed tumours probably do not lead to any changes in the enzyme activities. The splitting up of amylase into isoenzymes by polyacrylamide gel electrophoresis and its possible importance for the diagnosis of pathological processes are discussed. First results of the splitting up of the parotid lysozyme are reported.

Amylases↗
PubMed1977

[Clinical and experimental examination of the resorption capacity of the tympanic cavity mucosa (author's transl)].

In a clinical examination of 25 patients with a mesotympanic perforation of the ear drum, it was found after the administration of 35 mg pilocarpine hydrochloride in water or in agar gel into the tympanic cavity, that the mucous membrane of the middle ear complex possesses a significant resorption capacity. The salivation curves obtained in these tests displayed exactly the same characteristics as the curves obtained after administration of the same amount of pilocarpine to the nasal and tracheal mucosa. The results of mathematical processing of the salivation curves by computer (Hawlett-Packard 30) are also given in the study.

Absorption↗
PubMed1990

Esophageal motor activity and acid clearance.

Esophageal acid clearance normally occurs as a two-step process. The initial step of emptying most of the fluid volume contained within the esophagus occurs quickly by gravity or by one or two peristaltic sequences. However, volume clearance is distinct from acid clearance, and esophageal pH is restored to normal after volume clearance as the 1 mL or so of residual acid is neutralized by swallowed saliva in a stepwise fashion. A considerable body of evidence has accumulated suggesting that about half of patients with reflux disease have markedly prolonged acid clearance times. Within this group abnormalities or both volume clearance and salivation have been demonstrated. Volume clearance may be impaired as a result of a breakdown of the peristaltic mechanism commonly seen with severe esophagitis or by "re-reflux" of cleared fluid from within a hiatal hernia. Either way, the result is increased residual acidic fluid within the esophagus. The increased residual acid must be titrated with saliva that has so slight a neutralizing capacity that it takes about 7 minutes for the average person to secrete enough saliva to titrate 1 mL of 0.1 N HCl. Salivation itself is reduced in cigarette smokers and in patients using anticholinergic medications, thereby prolonging the process of mucosal neutralization in such persons. Whatever the mechanism of prolonged acid clearance for a particular individual, the overall result is of prolonged esophageal mucosal acid exposure, which makes the development of peptic esophagitis more likely.

Esophagitis, Peptic↗
PubMed1989

[The relationship between pilocarpine induced autonomic ganglia stimulating activity and salivary secretion of submandibular gland in pithed rat].

Superior cervical ganglion (SCG)-mediated effect of Pilocarpine (pilo.) on salivation of the rat submandibular gland was investigated. A total of 32 SD male rats, aged 12 weeks was divided into 4 experimental groups I to IV. They were anesthetized by pentobarbital (75 mg/kg, i.p.) and tracheotomized to allow artificial respiration. These rats were then ectomized only right SCG, leaving left SCG and injected with pilo. (8 mg./kg, i.v.). Rats of group I which were treated in the manner stated above were used as a control. Rats of group II and IV, of which adrenal glands were removed 18 hr before, were pithed 20 min before the injection of pilo. Rats of group III and IV were administered hexamethonium (C6) (1 mg/kg, i.v.). 5 min before the injection of pilo. Saliva from groups I to IV were collected separately from both salivary glands and flow rate of saliva were measured. Concentration of Na and K were also measured and total amounts of Na and K were calculated. 1) The flow rate induced by pilo. showed a tendency of increase in SCG-ectomized rats. 2) The flow rate showed also a tendency of increase in pithed rats. 3) The concentration and total amount of protein in saliva were decreased by SCG-ectomy. 4) The concentration of K was decreased in only SCG-ectomized rats whereas the total amount of K was closed in group I and II in spite of pithing and/or SCG ectomy. This reduction in K concentration seems to be caused by the increased flow rate as mentioned in paragraph 1). 5) SCG stimulating effect by pilo. was not antagonized, but rather activated by C6. 6) Submandibular ganglion-stimulating effect of pilo. was revealed in group III receiving C6, but this effect was extinguished in pithed rats of group IV. Considering of these results, it is proposed that SCG-stimulating ability of pilo., as shown previously by others, would be caused by activation of M1 receptor, which has sympathetic nerve stimulating effect on salivary glands, and may modify the salivation induced by stimulating effect of pilo. on M2 receptor. Moreover, results obtained with group III suggest that pilo. has submandibular ganglion-stimulating activity, although it's detailed mechanism is unknown.

Animals↗